Clopidogrel dosing and role of genetics: ELEVATE-TIMI 56 trial

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.B.B.S. [2]

Overview

The results of the ELEVATE-TIMI 56 trial were recently presented in AHA 2011 held at Orlando, Florida.

ELEVATE-TIMI 56 trial

• Hypothesis -
• Study design
  • Patient population
    • Multicenter, randomized, double-blind trial
    • Duration of study - 1 years
    • Intervention -
    • Primary end point -

• Limitations

• Results -
• Conclusions